MedTech Dive January 11, 2024
Analysts see the update as evidence Masimo may be rebounding after failing to meet their expectations earlier in the year.
Dive Brief:
- Masimo has reported preliminary fourth-quarter results and forecast 2024 sales that top analyst expectations.
- The healthcare business drove the difference between the expectations and the results. Masimo expects fourth-quarter healthcare sales of between $336 million and $341 million, compared to the consensus estimate of $325.8 million quoted by BTIG analysts.
- BTIG analysts and their peers at Stifel sent upbeat notes to investors about the results, framing the fourth-quarter beat and outlook for 2024 as signs that Masimo may be recovering after failing to meet their expectations earlier in the year.
Dive Insight:
Masimo cut its full-year...
Today's Sponsors
Today's Sponsor